EXACT Therapeutics AS (OSL:EXTX)
Norway · Delayed Price · Currency is NOK 0.8000
+0.1000 (14.29%)
At close: Aug 3, 2026
EXACT Therapeutics AS Income Statement
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 0.06 | - | 0 | 0.45 | 0.05 | |
Revenue Growth | - | - | -99.02% | 774.07% | - |
Gross Profit | 0.06 | - | 0 | 0.45 | 0.05 |
Selling, General & Admin | 28.9 | 23.13 | 22.31 | 14.12 | 17.99 |
Depreciation & Amortization Expenses | 3.68 | 2.43 | 2.09 | 2 | 1.82 |
Research & Development | 40.54 | 18.52 | - | - | - |
Other Operating Expenses | 11.81 | 8.78 | 23.98 | 25.11 | 39.36 |
Total Operating Expenses | 84.94 | 52.85 | 48.38 | 41.23 | 59.16 |
Operating Income | -84.88 | -52.85 | -48.38 | -40.77 | -59.11 |
Interest Income | 4.7 | 1.23 | 1.28 | 1.01 | 0.96 |
Interest Expense | -6.79 | -0.71 | -1.28 | -0.8 | -0.44 |
Total Non-Operating Income (Expense) | -2.09 | 0.52 | -0 | 0.21 | 0.52 |
Pretax Income | -86.97 | -52.33 | -48.38 | -40.57 | -58.59 |
Provision for Income Taxes | - | - | -0.05 | -0.46 | - |
Net Income | -86.97 | -52.33 | -48.33 | -40.1 | -58.59 |
Net Income to Common | -86.97 | -52.33 | -48.33 | -40.1 | -58.59 |
Net Income Growth | - | - | - | - | - |
Shares Outstanding (Basic) | 63 | 35 | 32 | 30 | 30 |
Shares Outstanding (Diluted) | 63 | 35 | 32 | 30 | 30 |
Shares Change | 82.42% | 8.10% | 6.94% | 0.06% | 99.48% |
EPS (Basic) | -1.37 | -1.51 | -1.51 | -1.34 | -1.95 |
EPS (Diluted) | -1.37 | -1.51 | -1.51 | -1.34 | -1.95 |
EPS Growth | - | - | - | - | - |
Free Cash Flow | -72.31 | -82.05 | -47.39 | -34.1 | -56.74 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Per Share | -1.14 | -2.37 | -1.48 | -1.14 | -1.89 |
Gross Margin | 100.00% | - | 100.00% | 100.00% | 100.00% |
Operating Margin | -143860.00% | - | -1085220.00% | -8971.05% | -113675.00% |
Profit Margin | -147403.00% | - | -1084200.00% | -8823.56% | -112673.00% |
FCF Margin | -122559.00% | - | -1062990.00% | -7503.15% | -109106.00% |
EBITDA | -81.19 | -50.42 | -46.29 | -38.84 | -57.28 |
EBITDA Margin | -137615.00% | - | -1038300.00% | -8545.08% | -110155.00% |
EBIT | -84.88 | -52.85 | -48.38 | -40.77 | -59.11 |
EBIT Margin | -143860.00% | - | -1085220.00% | -8971.05% | -113675.00% |
Effective Tax Rate | 0.00% | 0.00% | 0.10% | 1.14% | 0.00% |